menu
    • menu

    Company profile for Avirmax

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Avirmax, Inc. based in San Francisco Bay Area, is dedicated to the innovation, development, and manufacture of adeno-associated virus (AAV) vector mediated biotherapeutics using its proprietary protein therapeutics and Bac-to-AAV technologies. Avirmax’s AAV Innovation Platform, a robust streamlined assembly line of novel AAV vector discovery and development, enables us to become a powerhouse of rAAV therapeutics due to its h...
    Avirmax, Inc. based in San Francisco Bay Area, is dedicated to the innovation, development, and manufacture of adeno-associated virus (AAV) vector mediated biotherapeutics using its proprietary protein therapeutics and Bac-to-AAV technologies. Avirmax’s AAV Innovation Platform, a robust streamlined assembly line of novel AAV vector discovery and development, enables us to become a powerhouse of rAAV therapeutics due to its highly transducible AAV vectors with high titers at production and enhanced expression of gene of interest (GOI) in target cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AvirmaxUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    25503 Whitesell St, Hayward, CA 94541
    Telephone
    Telephone
    1(510) 397-2333
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://avirmax.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/avirmax-inc/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AvirmaxInc

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Avirmax Biopharma to Present at 2025 ARVO Annual Meeting
    Avirmax Biopharma to Present at 2025 ARVO Annual Meeting

    23 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/avirmax-biopharma-inc-to-present-at-the-2025-arvo-annual-meeting-in-salt-lake-city-302436454.html

    PR NEWSWIRE
    23 Apr 2025
    Share Share
    Avirmax Starts IND-Enabling Studies For ABI-201 Gene Therapy In Dry AMD
    Avirmax Starts IND-Enabling Studies For ABI-201 Gene Therapy In Dry AMD

    28 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/avirmax-biopharma-initiates-ind-enabling-studies-of-abi-201-a-breakthrough-gene-therapy-for-dry-age-related-macular-degeneration-302388894.html

    PR NEWSWIRE
    28 Feb 2025
    Share Share
    Avirmax Completes 1st Cohort Enrolls for ABI-110 Gene Therapy Trial
    Avirmax Completes 1st Cohort Enrolls for ABI-110 Gene Therapy Trial

    03 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/avirmax-biopharma-announces-completion-of-the-first-cohort-of-patient-enrollment-in-clinical-trial-of-abi-110-a-gene-therapy-for-wet-amd-including-pcv-302365936.html

    PR NEWSWIRE
    03 Feb 2025
    Share Share
    Avirmax CMC Delivers First GMP AAV Vector Lot For Clinical Trials
    Avirmax CMC Delivers First GMP AAV Vector Lot For Clinical Trials

    17 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/avirmax-cmc-successfully-delivers-first-gmp-lot-of-aav-vector-product-for-clinical-trial-use-302199876.html

    PR NEWSWIRE
    17 Jul 2024
    Share Share
    Avirmax ASGCT Scientific Presentations
    Avirmax ASGCT Scientific Presentations

    16 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/avirmax-inc-to-make-scientific-presentations-at-asgct-in-baltimore-302117506.html

    PR NEWSWIRE
    16 Apr 2024
    Share Share
    Vice President of Avirmax will Chair Sessions at the Conference in Baltimore
    Vice President of Avirmax will Chair Sessions at the Conference in Baltimore

    29 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vice-president-of-avirmax-inc-will-chair-sessions-at-the-27th-asgct-2024-annual-conference-in-baltimore-302103816.html

    PR NEWSWIRE
    29 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search